STI Self-Swab Testing for Telemedicine Abortion Patients

This study is looking at a new way to test for sexually transmitted infections (STIs) like chlamydia, gonorrhea, and trichomonas. It's for people having a medication abortion through telemedicine. The study wants to see if it's acceptable, easy to do, and if people will use a self-collected swab test for STIs at home. This could help more people get tested, especially if it's hard for them to get tested in person. Researchers will compare the results from people using the self-swab test to those who get in-clinic testing.

Study design
This is an exploratory study involving about 75 women aged 14 and older. It compares a group receiving telemedicine abortion care with a self-swab STI test to a group receiving in-clinic abortion care.
What's involved
If you are eligible and agree to participate, you would be asked to perform an STI self-swab test. The study will assess your experience and the results of the test.
Compensation
Not stated in the trial record.
Follow-up
Your acceptability and feasibility of the self-swab test will be assessed up to two weeks after you complete the intervention. The utilization of the self-collected STI screening will be measured for up to one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06951438

Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision

Recruiting
NAAges 14+InterventionalHealth services
Queen's Medical Center
~75 participants
Updated 2025-06-26 on ClinicalTrials.gov
What's tested:Self-swab collection PCR test for chlamydia, gonorrhea, trichomonas

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Utilization of self-collected STI screening at the time of telemedicine medication abortion provision
Measured over 1) up to one year 2) up to one year
+2 more outcomes measured
Sexually Transmitted Disease (STD)
Gonorrhea
Chlamydia
Trichomonas Infection
1 sites across 1 states
Hawaii1

Opens a ready-to-send draft in your own email app — review before sending.

  • Utilization of self-collected STI screening at the time of telemedicine medication abortion provision1) up to one year 2) up to one year

    Utilization rates will be reported as a percentage. Both enrollment in the study, as well as utilization of the actual STI testing services, will be reported as measures of utilization. The former (1) will be reported as the percentage of eligible patients who chose to enroll in the study, while the latter (2) will be reported as the percentage of enrolled patients who submitted samples for STI testing.

  • Acceptability of self-collected STI screening at the time of telemedicine medication abortion provisionUp to two weeks after completion of the intervention

    Acceptability will be measured using a modified version of the Digital Health Acceptability Questionnaire (DHAQ) which is a validated survey that is used to assess acceptability and feasibility of telehealth-based interventions. The first five questions (1-5) are validated to assess attitude toward the service as a means to address healthcare needs, while the second five questions (6-10) address individual capacity and effort to use the telehealth intervention. A copy of this survey can be found in Table A. This is a 10 question survey of Likert scales from 1 to 5, with 1 being "Strongly Disagree" and 5 being "Strongly Agree". We will calculate median and IQR across the domains of the DHAQ to determine a median acceptability score, which will be calculated using the scores from questions 1-5.

  • Feasibility of self-collected STI screening at the time of telemedicine medication abortion provision1) Up to two weeks after completion of the intervention

    Feasibility will be measured using a modified version of the Digital Health Acceptability Questionnaire (DHAQ) which is a validated survey that is used to assess acceptability and feasibility of telehealth-based interventions. The first five questions (1-5) are validated to assess attitude toward the service as a means to address healthcare needs, while the second five questions (6-10) address individual capacity and effort to use the telehealth intervention. A copy of this survey can be found in Table A. This is a 10 question survey of Likert scales from 1 to 5, with 1 being "Strongly Disagree" and 5 being "Strongly Agree". We will calculate median and IQR across the domains of the DHAQ to determine a median acceptability score, which will be calculated using the scores from questions 6-10.